The intestinal epithelium can limit enteric pathogens by producing antiviral cytokines, such as IFNs. Type I IFN (IFN-α/β) and type III IFN (IFN-λ) function at the epithelial level, and their respective efficacies depend on the specific pathogen and site of infection. However, the roles of type I and type III IFN in restricting human enteric viruses are poorly characterized as a result of the difficulties in cultivating these viruses in vitro and directly obtaining control and infected small intestinal human tissue. We infected nontransformed human intestinal enteroid cultures from multiple individuals with human rotavirus (HRV) and assessed the host epithelial response by using RNAsequencing and functional assays. The dominant transcriptional pathway induced by HRV infection is a type III IFN-regulated response. Early after HRV infection, low levels of type III IFN protein activate IFN-stimulated genes. However, this endogenous response does not restrict HRV replication because replication-competent HRV antagonizes the type III IFN response at pre-and posttranscriptional levels. In contrast, exogenous IFN treatment restricts HRV replication, with type I IFN being more potent than type III IFN, suggesting that extraepithelial sources of type I IFN may be the critical IFN for limiting enteric virus replication in the human intestine.
The intestinal epithelium can limit enteric pathogens by producing antiviral cytokines, such as IFNs. Type I IFN (IFN-α/β) and type III IFN (IFN-λ) function at the epithelial level, and their respective efficacies depend on the specific pathogen and site of infection. However, the roles of type I and type III IFN in restricting human enteric viruses are poorly characterized as a result of the difficulties in cultivating these viruses in vitro and directly obtaining control and infected small intestinal human tissue. We infected nontransformed human intestinal enteroid cultures from multiple individuals with human rotavirus (HRV) and assessed the host epithelial response by using RNAsequencing and functional assays. The dominant transcriptional pathway induced by HRV infection is a type III IFN-regulated response. Early after HRV infection, low levels of type III IFN protein activate IFN-stimulated genes. However, this endogenous response does not restrict HRV replication because replication-competent HRV antagonizes the type III IFN response at pre-and posttranscriptional levels. In contrast, exogenous IFN treatment restricts HRV replication, with type I IFN being more potent than type III IFN, suggesting that extraepithelial sources of type I IFN may be the critical IFN for limiting enteric virus replication in the human intestine.
enteric virus | interferon | human enteroids | human rotavirus T he human small intestinal epithelium is the primary site of infection and replication for many gastrointestinal pathogens. However, fundamental knowledge about intestinal epithelial cellpathogen interactions in humans is limited as a result of the impracticality of studying these cells in vivo. Modeling these interactions in vitro is difficult because many human enteric pathogens fail to replicate or replicate poorly in cancer cell lines derived primarily from the human colon (1) (2) (3) (4) . Human intestinal enteroids (HIEs) represent a new in vitro model of the human small intestinal epithelium; this model was developed following advances in stem cell biology, and it recapitulates many of the biological and physiological properties of the human small intestine in vivo (5, 6) . Unlike other in vitro models, HIEs are easily established from nontransformed small intestinal tissue, can be maintained on a long-term basis, and contain a stem cell niche and the diversity of intestinal epithelial cell types (enterocytes, goblet, enteroendocrine, and Paneth cells) present in vivo (6, 7) . HIEs allow for comparisons of intestinal host responses across genetically diverse individuals (8) and reproduce many of the in vivo pathophysiological properties of infection by a human enteric viral pathogen, human rotavirus (HRV) (9) .
HRVs are the major etiology of severe diarrhea in children under the age of 5 y worldwide, resulting in an estimated 215,000 deaths annually (10) . HRVs replicate to high titers in humans but replicate poorly or not at all in small animal models (11, 12) . This host restriction of HRV in animal models is based on properties of host and virus and is not unique to HRVs; it is exhibited by other human enteric viruses such as human noroviruses and adenoviruses (12) (13) (14) . In addition, HRV generally replicates to lower titers than animal rotaviruses in transformed cell lines (2) . Therefore, most knowledge of rotavirus-host interactions comes from studies that analyzed animal rotavirus replication in animal models or in transformed cell lines (15) (16) (17) (18) . Induction of the adaptive immune system and secretion of IgA are critical factors in protecting the host against rotavirus infection based on in vivo models of animal rotavirus infection (19, 20) . However, in a naïve host, the adaptive immune system is not fully activated until several days after primary infection (21, 22) . Epithelial cells mount an early innate immune response to infection, and this immediate antiviral response is often crucial in limiting viral replication and ensuring tissue viability until the adaptive immune response is activated (22) (23) (24) (25) .
IFNs are potent antiviral cytokines that function in an autocrine and paracrine fashion following the detection of specific pathogen-associated molecular patterns (PAMPs) (26) . Currently, three classes of IFNs have been identified: type I, type II, and type III IFN (27, 28) . Type II IFN (IFN-γ) is mainly produced by immune cells, whereas type I (IFN-α/β) and type III IFN (IFN-λ) are
Significance
Understanding host-enteric virus interactions has been limited by the inability to culture nontransformed small intestinal epithelial cells and to infect animal models with human viruses. We report epithelial responses in human small intestinal enteroid cultures from different individuals following infection with human rotavirus (HRV), a model enteric pathogen. RNA-sequencing and functional assays revealed type III IFN as the dominant transcriptional response that activates interferon-stimulated genes, but antagonism of the IFN response negates restriction of HRV replication. Exogenously added IFNs reduce HRV replication, with type I IFN being most effective. This highlights a paradox between the strong type III transcriptional response and the weaker functional role of type III IFN in human enteric viral restriction in human small intestinal cultures.
produced by immune and epithelial cells and thus are relevant to host-pathogen interactions at epithelial surfaces (27) . The type I IFN receptor is expressed on most cell types, whereas the type III IFN receptor is primarily restricted to epithelial cells (29) . Type I and III IFNs are generally induced by similar stimuli (30) . Stimulation of an IFN receptor leads to the induction of a variety of IFN-stimulated genes (ISGs), and ISG-encoded proteins are effector molecules of the antiviral state (31) . One unanswered question is whether unique type I and III IFN expression profiles are produced by the human intestinal epithelium in response to different stimuli or viral pathogens.
Based on studies in mice, the innate response to rotavirus infection is complex and virus strain-specific; homologous (murine) rotavirus replication is insensitive to IFNs whereas type I and III IFNs restrict heterologous (nonmurine) rhesus rotavirus (RRV) replication (17, 32, 33) . Host restriction is hypothesized to be the basis for attenuation of an HRV vaccine widely used today, RotaTeq, which is derived from a heterologous bovine strain (34) . Although a wealth of knowledge has been gained from mouse studies with nonhuman enteric viruses, these models do not account for evolutionary differences in host and pathogen. Subtle but possibly important differences exist between human and mouse type I and III IFN systems and between human and mouse rotaviruses (18, (35) (36) (37) (38) , necessitating functional studies of interactions between human host cells and human enteric pathogens.
HIEs represent a new model to study epithelial cell innate immune responses to human enteric pathogens. Is Reproducible Across HIEs from Different People. HIEs are novel, physiologically active, nontransformed cultures that are increasingly used to study human pathogen-host interactions (5, 8, 9, 39, 40) . We first evaluated the variability in the transcriptional response to HRV infection in HIEs by analyzing transcriptomes from one jejunal HIE culture by microarray analysis. Independent HIE cultures (individual j11) were mock-inoculated or inoculated with HRV (strain Ito) at a high multiplicity of infection (MOI). Three technical replicates for each condition were analyzed at 6 and 10 h post infection (hpi), as HRV-infected cells lyse by 14 hpi (9) . The percentage of infected cells was 51.4 ± 14.7% (mean ± SD of triplicate cultures) as assessed by flow cytometry, demonstrating that the HRV-infected cultures contain infected cells and uninfected bystander cells. Principal component analysis showed that the first principal component (time point in hpi) explained 42% of the variance in the global gene expression profiles, indicating that time point is an important covariate. The second principal component explained 22% of the variance and discriminated the expression profiles based on infection status (Fig. 1A) . Although time and infection status influenced HIE transcriptional profiles, the intraculture transcriptional profiles for a specific combination of time and infection status clustered together.
We next evaluated interculture variability in the HIE response to HRV infection by microarray analysis. Jejunal HIEs from three individuals (j2, j3, and j11) were mock-or Ito-HRV-infected at a high MOI. The percentages of HRV-infected cells were 52.9% (j2), 43.9% (j3), and 47.7% (j11). Hierarchical clustering of global gene expression profiles accounting for time point revealed that HIEs first clustered by each individual and then by infection status (Fig. 1B) , indicating significant baseline variability between HIEs derived from different individuals. To assess if the response to HRV infection was conserved between HIEs from the three different people, we calculated gene expression fold changes with HRV infection across more than 20,000 transcripts from each individual. We observed a significant correlation between HRVinduced transcriptional changes in the three individuals' HIEs; the lowest correlations of 0.18 at 6 hpi (between j2 and j11) and 0.31 at 10 hpi (between j3 and j11) correspond to P values <2.2 × 10 −16 (Fig. 1C) . Notably, 18 genes at 6 hpi and 28 genes at 10 hpi ranked in the top 100 up-regulated genes in each of the three HIEs' transcriptional profiles (P < 10 −5 for both time points, permutation-based approach; Materials and Methods and Fig. 1D ). Further analysis of these genes revealed that 16 of 18 and 15 of 28 were ISGs at 6 and 10 hpi, respectively (Fig. S1A) . Thus, despite a baseline variability at the transcriptional level between HIEs from different individuals, all three mounted a conserved ISG transcriptional response to HRV infection.
RNA-Sequencing Analysis of HIEs Reveals IFN Signaling Is the Dominant Pathway Induced by HRV Infection. We next performed an RNA-sequencing (RNA-seq) experiment on mock-and HRVinfected HIE cultures. RNA-seq more accurately measures transcriptional activity than microarrays, particularly of low-expressing genes (41) . Because minimal transcriptional variability was observed between samples from the same individual (Fig. 1A) , one mock-and one HRV-infected culture of HIEs from two individuals (j2 and j11) were sequenced at 6 hpi. Approximately 25% of the RNA-seq reads in the two infected samples mapped to the rotavirus genome, confirming that the infection was robust ( Fig. 2A) .
Comparison of microarray and RNA-seq experiments showed significant correlation between baseline gene expression estimates (Spearman correlation R = 0.67, P < 2.2 × 10
−16
). Transcripts present at levels >8 in the microarray dataset (referred to here as medium-and high-expressing genes) correlated relatively well with transcript levels in the RNA-seq dataset (Fig. 2B) . However, there was a wide distribution of transcript levels in the RNA-seq dataset for genes with expression <8 in the microarray dataset, confirming that RNA-seq improved the quantification and resolution of transcript levels for low-expressing genes.
To identify genes involved in the HIE response to infection, differential expression analysis was performed using HIE origin (j2 or j11) and infection status as the explanatory variables. We identified a total of 230 genes differentially expressed by infection status [false discovery rate (FDR) < 0.05], 172 were up-regulated and 58 were down-regulated ( Fig. 2C and Fig. S1B ). Ingenuity Pathway Analysis of these 230 genes revealed that the pathways most affected by HRV infection were IFN signaling (P = 9.8 × 10
) and activation of IRF by cytosolic pattern recognition receptors (P = 2.7 × 10
−12
). Examination of those genes that significantly changed with infection (FDR < 0.05) and also had an absolute log 2 fold change ≥1 revealed 63 genes, all of which were up-regulated. Analysis of these 63 genes again demonstrated that the top induced pathway during HRV infection was IFN signaling (P = 9.6 × 10 −16
; Fig. S1C ). Of these 63 genes, 55 were ISGs and three were IFNs; all three belonged to the type III IFN family (Fig. S1D ). Type I (IFNB1) and type III IFN (IFNL1) had similarly low basal expression levels in the mock-inoculated HIEs (Fig. 2D , purple symbols), but only type III IFN (IFNL1, IFNL2, IFNL3) was significantly up-regulated with infection ( Fig. 2 C and D) . We identified baseline expression levels of ISGs (total, n = 295) in the mock-inoculated HIE cultures. Gene-set enrichment analysis showed that ISGs were significantly up-regulated in HRV-infected cultures (P < 2.2 × 10 −16 , Kolmogorov-Smirnov test; Fig. S1E ). Overall, IFN-ISG signaling is the dominant pathway induced at the transcriptional level in HRV-infected HIEs.
The ISG Response to HRV Infection of HIEs Is Regulated by Signaling
Through the Type III IFN Receptor. Infection-induced gene expression changes were verified by quantitative RT-PCR (RT-qPCR). Transcript levels of multiple IFNs and ISGs were compared between mock-and HRV-infected jejunal HIE cultures at 6 hpi. The type III IFNs were highly up-regulated in infected cultures from six individuals, with 2-3(log 10 ) increases in transcript levels of IFNL1 and IFNL2, whereas type I IFNs were only slightly up-regulated (<1-10-fold; Fig. 3A) . ISGs constituted the majority of the top upregulated genes. Six ISGs (IFI44L, IFIT1, RSAD2, MX1, OAS2, and HERC5) with varying basal expression levels (Fig. 2D , red symbols) were assessed for their fold up-regulation by RT-qPCR. Up-regulation in the infected cultures ranged from 2.7-fold (MX1) to 35.3-fold (IFIT1; Fig. 3B ).
Based on the robust induction of the type III IFNs and minimal to no induction of type I IFN (IFNA2 and IFNB1) transcripts, we hypothesized that ISG induction was regulated by signaling through the type III IFN receptor. We tested this hypothesis by performing HRV infection in the presence of blocking antibodies to the type I or III IFN receptors. Basal expression levels of the six previously tested ISGs in mock-inoculated HIEs from six was compared with infection performed in the presence of blocking antibodies to the type III IFN receptor (anti-type III IFN), blocking antibodies to the type I IFN system (anti-type I IFN), and antibodies to both the type III IFN receptor and type I IFN system (anti-both IFNs). HIEs were inoculated with HRV and, after 1.5 hpi, the virus inoculum was washed off and HIEs were resuspended in medium with or without antibodies to the indicated IFN receptors. HIEs were harvested for transcriptional (RT-qPCR) analysis at 6 hpi. The fold upregulation of each ISG in the control infections without receptor-blocking antibodies (shown in B) was normalized to 100% and then compared with the up-regulation of individual ISGs under each receptor-blocking condition. Data in A-C are of HIEs from six individuals and are a compilation of three independent experiments. Results are expressed as geometric mean ± 95% confidence interval (CI) of the geometric mean (n = 6 biological replicates) in A and as arithmetic mean ± SEM (n = 6 biological replicates) in B and C. Statistical analyses were performed by Mann-Whitney U test in A and C. (D) Expression levels of type III IFN (IFNL1), type I IFN (IFNB1), and the ISG IFI44L were assessed from mock-and HRV-inoculated HIEs (MOI of 4) from individual j3 at 3, 10, and 22 hpi. Each data point represents geometric mean ± 95% CI of the geometric mean of four technical replicates.
individuals were not significantly different with or without blocking antibody treatment (P > 0.05, Wilcoxon signed-rank test, n = 6 biological replicates), suggesting minimal to no baseline IFN regulation of these six ISGs in mock-inoculated HIEs. In addition, type III IFN (IFNL1 and IFNL2) transcriptional levels were not significantly different between HRV infections performed with or without type III IFN receptor-blocking antibody treatment (P > 0.05, Wilcoxon signed-rank test, n = 6 biological replicates), indicating that this antibody did not induce nor suppress IFNL transcriptional activity. However, HRV infection performed in the presence of blocking antibodies to the type III IFN receptor significantly reduced the induction of the six ISGs analyzed, ranging from a 66% reduction in MX1 transcript levels to an 81% reduction in RSAD2 transcript levels compared with HRV infection without receptor-blocking antibodies (Fig. 3C) . Maximum (100%) up-regulation of each ISG corresponds to the fold inductions shown in Fig. 3B . HRV infection in the presence of a control antibody (isotype matched to the type III IFN receptor-blocking antibody) did not decrease ISG levels compared with infection without antibodies. Infection performed in the presence of blocking antibodies to type I and type III IFN receptors failed to further suppress ISG levels compared with type III IFN receptor blockade alone (Fig. 3C ). These data suggest that signaling through the type III IFN receptor largely regulates ISG induction in response to HRV infection in HIEs.
Analysis of IFN-ISG transcriptional kinetics at three additional time points showed that IFN transcripts were present at 3 hpi and decreased by ∼1 log 10 at 10 hpi, at which point their levels plateaued (Fig. 3D) . In contrast, up-regulation of ISG transcripts (assessed by using IFI44L as a marker) was not observed at 3 hpi but was present by 10 hpi, demonstrating that the type III IFN response preceded the ISG response. Together, these data suggest that HRV infection of HIEs results in robust up-regulation of type III IFN, which in turn activates the type III IFN receptor and leads to the induction of ISGs.
HRV Replication in HIEs Is Not Restricted by Endogenously Produced
IFN. HRV infection of epithelial cells in the HIE model induced a type III IFN-regulated ISG response, and IFN receptor signaling appeared to start between 3 and 6 hpi, as ISGs were up-regulated at 6 hpi but not at 3 hpi (Fig. 3) . To assess whether the endogenous host IFN response can restrict rotavirus replication, HRV replication was assessed in the presence of IFN-receptor blocking antibodies. We hypothesized that inhibiting the host IFN response by blocking IFN signaling would increase virus titer yields. However, blockade of neither the type I nor type III IFN receptors during multiple rounds of replication significantly increased viral yields by 60 hpi (P = 0.75, Kruskal-Wallis test; Fig. 4 ). In addition, neither replication of Ito-HRV nor RRV was enhanced by simultaneous blockade of type I and type III IFN receptors for 60 h (P > 0.05, Mann-Whitney U test). These data suggest that, although homologous HRV and heterologous RRV induce a type III IFN response at the epithelial level (Fig. S2 ), this host cell response does not restrict viral growth because rotavirus grows to similar titers regardless of whether the type III IFN response is neutralized.
Different Strains of Rotavirus and a dsRNA Analog Preferentially
Induce IFNL over IFNB in HIEs. The preceding experiments were primarily performed with the human strain Ito, genotype G3P [8] . Rotavirus infection of HIEs recapitulates the host-range restriction observed in vivo; human strains infect and replicate at higher levels than animal strains such as simian RRV in HIEs (9) . To assess whether the type III IFN induction in response to Ito-HRV infection was strain-specific, HIEs were infected at the same MOI with an additional human strain (Wa, G1P [8] ) and a simian strain (RRV; G3P [3] ). Irrespective of virus strain, the pattern of IFN induction was similar; all three strains led to increased fold induction of IFNL1 compared with IFNB1 (Fig. S2) . However, IFNL1 levels were significantly higher in HIEs infected with HRVs than with RRV, suggesting that type III IFN transcriptional intensity is strain-specific depending on the host susceptibility in HIEs.
Next, we evaluated if the preferential up-regulation of IFNL1 instead of IFNB1 with rotavirus infection was intestinal segmentor rotavirus-specific. Responses of 12 different individuals' HIEs showed that IFNL1 induction in response to HRV infection was not significantly different across the three sections of the small intestine (P = 0.28, Kruskal-Wallis test), but IFNL1 fold upregulation was ∼10-100-fold more than IFNB1 in each intestinal section (Fig. 5A ) despite similar basal expression levels of the two IFNs in uninfected HIEs (Fig. 2D, purple symbols) . We also tested the response to the dsRNA analog poly(I:C), which causes robust induction of the type I IFN system in transformed and nontransformed cell lines (42, 43) . Unlike rotavirus or other viruses (24, 44) , poly(I:C) does not antagonize IFN transcriptional responses. Similar to the response to rotavirus, all 12 HIEs treated with poly(I:C) exhibited significantly increased IFNL1 transcript fold up-regulation (range, 419-225,332 fold) compared with IFNB1 (range, 1-142 fold; Fig. 5B ). These findings indicate that HIEs preferentially respond to rotavirus and dsRNA stimuli with type III IFN rather than type I IFN.
The specific rotavirus PAMP(s) recognized by cellular pathogen recognition receptors (PRRs) is unclear. Rotavirus replication was not thought to release free dsRNA genome into the cell (45) . However, dsRNA has recently been detected independent of viroplasms in animal rotavirus-infected MA104 cells (46) . dsRNA is a potent PAMP for many other viruses (47) , and it is therefore pertinent that the dsRNA analog poly(I:C) and HRV induced similar IFN transcriptional profiles in HIEs. Staining HIEs for dsRNA and the viroplasm marker nonstructural protein (NSP2) revealed their colocalization in the cytoplasm of infected cells as well as dsRNA independent of viroplasms (Fig. 5C ). These data demonstrate the presence of viroplasm-independent dsRNA in HRV-infected cells that could be the PAMP recognized by cellular PRRs. (Fig. 3C) , suggesting that type III IFN (IFN-λ) protein was secreted during infection and engaged its receptor. Therefore, either (i) HRV replicated despite high quantities of type III IFN protein or (ii) low levels of type III IFN protein produced during infection were sufficient to induce ISGs but insufficient to restrict viral growth. IFN protein production was evaluated in supernatants from mock-inoculated and HRVinfected HIE cultures by ELISA. Despite robust up-regulation of IFNL1 transcripts at 6 hpi (Fig. S3A) , IFN-λ1 and IFN-λ2/3 proteins were below the limit of detection in the supernatant from infected HIEs at multiple time points (6-48 hpi) and under multiple different conditions, including from a homogenate of supernatant and cell lysate (Table S1 ). These data suggested that HRV infection induced type III IFN protein at levels below the limit of detection of standard ELISAs but sufficient to induce ISGs. This was confirmed by observing that exogenous treatment of HIEs with concentrations of IFN-λ1 protein below the limit of detection of standard ELISAs (<2 U/mL; Materials and Methods) induced ISGs (Fig. 6A) to similar levels as HRV (Fig. 3B) . Rotavirus infection of transformed cells also induces the neutrophil chemoattractant IL-8 (48) . High but similar levels of IL-8 were detected in HIE supernatants from mock-and HRV-infected samples previously tested for IFN (P > 0.05 at each time point, MannWhitney U test; Fig. S3B) , showing that not all host proteins were as affected by HRV infection as type III IFN.
Rotavirus antagonizes IFN production pretranscriptionally in a variety of cell lines (HT29, Caco-2, and 293T) through degradation of factors involved in IFN transcription (35, (49) (50) (51) . We observed robust type III IFN transcription with HRV and poly (I:C) treatment (∼100-1,000-fold increases; Fig. 5 ), but protein was detected only from poly(I:C)-treated HIEs at 8 hpi (Fig. 6B) . We next evaluated the possibility of rotavirus-mediated inhibition of IFNL1 translation in HIEs treated with HRV and/or poly(I:C). IFN-λ1 protein levels were below the limit of detection from mock-and HRV-infected HIEs, but were 224 pg/mL from poly (I:C)-treated HIEs at 20 hpi (Fig. 6C) . The IFN-λ1 protein level significantly decreased to 41 pg/mL when poly(I:C)-treated HIEs were also infected with HRV. These data (Fig. 6 B and C) indicate a rotavirus-mediated posttranscriptional partial suppression of host IFNL1 mRNA translation. Of note, IFN-β1 protein from HIE supernatant was below the limit of detection by ELISA (sensitivity, 2 pg/mL) for each of the four conditions described in Fig. 6C at 20 hpi.
Rotavirus antagonism of the host response is primarily mediated through the nonstructural proteins NSP1 and NSP3, which are present only in cells infected with replication-competent virus (24) . We assessed if viral antagonism of the IFN response in HIEs was a replication-dependent process by treating HIEs with purified, inactivated HRV particles that contain the dsRNA genome, structural proteins, and can enter cells but do not transcribe viral mRNAs or express nonstructural proteins (16, 52) . Inactivated HRV induced ∼10-fold higher transcript levels of IFNL1 and IFNB1 compared with replication-competent virus early after infection (Fig. 7A) , demonstrating that the robust IFNL1 transcriptional response induced by replication-competent HRV is partially antagonized at a pretranscriptional state by infectious virus. Furthermore, high levels of IFN-λ1 protein were detected from HIEs treated with inactivated (i.e., replication-incompetent) HRV (Fig. 7B ), but only if infection was performed in the presence of antibody to the type III IFN receptor, suggesting that secreted IFN-λ1 protein rapidly bound its receptor and did not remain free in the supernatant for an extended duration. A similar technique of using receptor-blocking antibodies to enhance cytokine detection has been described for IL-4 (53). Thus, IFN transcriptional induction in HRV-infected HIEs is replicationindependent, but pre-and posttranscriptional antagonism of the IFN response in HRV-infected HIEs is replication-dependent.
Exogenous IFN Treatment Restricts Rotavirus Growth in HIEs.
Endogenously produced IFN did not restrict HRV growth in HIEs (Fig. 4) . However, endogenous type III IFN restricts animal rotavirus replication in mice (54, 55) . The mouse epithelium was thought to produce the type III IFN in vivo, although immune cells can also produce type III IFN (54, 56, 57) . In contrast, murine type I IFN predominantly originates from lamina propria immune cells during rotavirus infection (58) . We simulated the presence of surrounding lamina propria immune cells by adding IFN before infection to compare the potential of exogenous type I and type III IFN to restrict rotavirus growth in HIEs.
Anti-rotavirus efficacy of type I IFN vs. type III IFN was compared by pretreating HIEs for 24 h with escalating doses of IFN-λ1 or IFN-β1 ranging from 100 to 10,000 U/mL. IFN was subsequently washed off, and the HIEs were infected with HRV at a low MOI to allow for multiple rounds of replication. IFN-λ1 and IFN-β1 inhibited HRV replication, but inhibition by IFN-λ1 was weaker than IFN-β1 at all concentrations (Fig. 8A) . Maximal inhibition of HRV replication by IFN-λ1 (79%) was achieved at 1,000 U/mL of IFN-λ1. In contrast, each 10-fold increase in IFN-β1 concentration reduced viral replication by ∼10-fold, with replication 90% inhibited with 100 U/mL of IFN-β1 and completely inhibited with 10,000 U/mL IFN-β1 (Fig. 8A) .
Our studies focused on IFN-λ1 and IFN-β1 because we did not find differences in transcriptional up-regulation between IFNL1-3 and because IFNB1 was the only type I IFN that was even slightly up-regulated (Fig. 3A) . However, heterogeneity in the antiviral properties of different type I and type III IFN variants has been reported with respect to other viruses (59, 60) . To compare efficacies of alternative type I and type III IFNs, HIEs were pretreated with IFN-λ3 (type III IFN) or IFN-α2 (type I IFN) and compared with their analogs, IFN-λ1 and IFN-β1, respectively. There was no significant difference between the two type III IFNs; both reduced viral replication by ∼80% (Fig. 8B) . However, pretreatment with IFN-β1 was significantly more protective than IFN-α2, indicating heterogeneity in the anti-rotavirus efficacy of the different type I IFNs. The HRV replication cycle in HIEs is rapid, with new progeny virus present by 7 hpi (9). To evaluate the time needed for IFN to establish an antiviral state, HIEs were treated for 6 or 24 h with IFN-λ1 or IFN-β1 before HRV infection. Following 6 h of pretreatment, IFN-λ1 and IFN-β1 reduced viral replication by 62% and 93%, respectively (Fig. 8C) . After 24 h of pretreatment, the antiviral efficacy of IFN-λ1 increased an additional 26% (88% protection), whereas the antiviral efficacy of IFN-β1 was only slightly enhanced to 99% after 24 h of pretreatment. Thus, exogenous IFN-β1 induced a faster and more effective anti-rotavirus state in epithelial cells than IFN-λ1.
The protective effects of IFN-λ in acute rotavirus infection in mice are enhanced by IL-22, which also cured chronic murine rotavirus infection (54, 61) . In the HIE model, pretreatment with IL-22 decreased HRV replication by 54% (Fig. 8D) . However, IL-22 did not significantly enhance the efficacy of low-dose (100 U/mL) or high-dose (1,000 U/mL) IFN-λ1 under the conditions tested. In conjunction with the results from Fig. 8A , these data demonstrate that the anti-HRV efficacy of IFN-λ saturates between 80% and 90% in HIEs, regardless of whether higher doses or an additional cytokine (IL-22) are used.
IFNs are typically present at very low basal levels before infection in vivo and are induced following detection of microbial PAMPs during infection (62) . To simulate this condition, HIEs were first infected with HRV and, 1.5 h later, exogenous IFN-λ1 or IFN-β1 was added to the maintenance media for the duration of the infection. At 24 and 48 hpi, viral growth in IFN-λ1-or IFN-β1-treated HIEs was reduced by ∼50-55% (IFN-λ1) and 79% (IFN-β1) compared with that in untreated HIEs (Fig. 8E ). Viral growth was not further restricted by treating HIEs during infection with a combination of 1,000 U/mL IFN-λ1 and 1,000 U/mL IFN-β1 compared with 1,000 U/mL IFN-β1 alone.
Discussion
HIEs provide a new model to evaluate the human small intestinal epithelial response to infection and assess human host effects by generating HIEs from multiple individuals. We found that the basal human epithelial transcriptome differs significantly between HIEs from different individuals, and this person effect was more pronounced than the response to enteric viral infection. These findings highlight that transcriptional data from single individual sources, such as cell lines, may have limited generalizability as they cannot capture the distinct transcriptional signatures exhibited by different individual sources and across small intestinal segments (63) . This inherent variability captured in the HIE model provides a unique opportunity to study similarities and differences in susceptibility to enteric infection among individuals. A preferential type III vs. type I IFN response to viral infection and dsRNA analogs does not appear to be common to all human epithelial cells. Whereas primary hepatocytes also respond to HBV/HCV and poly(I:C) predominantly with type III IFN (66, 67) , primary lung epithelial cells respond to influenza virus infection from four individuals (j2, j3, j6 , and j11) were treated with increasing doses of IFN-λ1, and ISG expression was assessed after 3 h by RT-qPCR. Data are of HIEs from four individuals and are a compilation of two independent experiments. Results are expressed as geometric mean ± 95% CI of the geometric mean (n = 4 biological replicates). (B) HIEs (j3) were mock-inoculated, HRV-inoculated (MOI of 10), or treated with poly(I:C) (30 μg/mL). After 1.5 hpi, HIEs were washed and resuspended in new medium, which was analyzed at 8 hpi for secreted IFN-λ1 by ELISA. (C) HIEs (j2) were mock-inoculated, HRV-inoculated (MOI of 10), treated with poly(I:C) (100 μg/mL), or HRV-inoculated (MOI of 10) and treated 10 min later with poly(I:C) (100 μg/mL). After 1.5 hpi, HIEs were washed and resuspended in new medium, which was analyzed at 20 hpi for secreted IFN-λ1 by ELISA. In B and C, data from one representative experiment of three independent experiments is presented as arithmetic mean ± SD of three technical replicates. Statistical analyses in C were performed by Student's t test. , and the ISG IFI44L was assessed at 6 hpi by RT-qPCR. Each data bar represents the geometric mean ± 95% CI of the geometric mean (n = 4 technical replicates). Statistical analyses were performed by Mann-Whitney U test. (B) HIEs were infected as described in A and, after 1 h, HIEs were washed and resuspended in medium containing type III IFN receptor-blocking antibody (25 μg/mL anti-IL28RA). The media was analyzed at 20 hpi for secreted IFN-λ1 by ELISA. Data from one representative experiment of two independent experiments is presented as arithmetic mean ± SD of three or four technical replicates.
and poly(I:C) with type I and III IFN (43, 68) . Thus, the type of IFN induced in response to infection appears to be cell-and/or virus-specific rather than a pan-epithelial intrinsic response. The specific cellular factors that predispose induction of type III IFN or type I IFN are unclear because regulation of IFN is complex. Both types of IFN are induced by similar stimuli and generally rely on similar transcription factors, such as NF-κB and the IRF family (30) , but preferential activation of type III IFN may be influenced by other transcription factors (69). In addition, peroxisomal content (70) and cell differentiation status (70) may significantly influence type III IFN induction. It is notable that the rotavirus capsid protein VP4 has a peroxisomal targeting motif (71) and that rotavirus infection of HIEs requires differentiated HIEs (9) . Whether any of these factors influences the preferential type III IFN innate response of HIEs to HRV and poly(I:C) remains to be determined.
The predominant type III IFN response and its regulation of ISG induction observed in our studies with HIEs is consistent with previous studies reporting that murine intestinal epithelial cells from poly(I:C)-injected and murine rotavirus-infected mice exhibit equal or greater fold inductions of type III IFN than type I IFN transcripts (17, 55, 56, 58) . This contrasts with results using transformed human colonic cell lines that respond to rotavirus infection and poly(I:C) with type I IFN-β at the transcript and protein levels, and type I IFN regulates ISG induction in these cells (16, 42, 72) . Transformed cells often have significant deficits in their response to pathogens, including in IFN signaling pathways (73, 74) . It seems likely that this critical difference in IFN responses to rotavirus and poly(I:C) between immortalized cell lines and nontransformed HIE cultures is partially attributed to their transformation status.
Despite robust up-regulation of type III IFN at the transcriptional level, rotaviral replication was not enhanced by neutralization of the type III IFN receptor in HIEs. This result was unexpected because enteric viral replication (rotavirus, reovirus, murine norovirus) is enhanced in mice lacking the type III IFN receptor (54) (55) (56) 75) , even though it is notable that neutralization of the type III IFN response had a limited effect on reovirus replication (approximately twofold increase in viral transcripts) in a human colonic transformed cell line (70) . The basis for the apparent discrepancy may be multifactorial and include differences in how the IFN system was blocked (neutralizing antibodies vs. receptor KOs), development of alternate compensatory pathways in IFN-KO mice, and/or differences in human and mouse type III IFN subtype expression (37, 38) . Regardless of these differences, HRV infection inhibited the IFN response by HIEs. Most pathogenic viruses, including rotavirus, have developed ways to subvert IFN responses at multiple steps in their biologic pathways (24, 44) . Rotavirus evades the host innate response primarily through its nonstructural proteins NSP1 and NSP3, and the structural protein VP3 has recently been shown to antagonize the cellular RNaseL antiviral response as well (33, 76) . In several in vitro models, rotavirus NSP1 inhibits the host IFN response by preventing IFN from being transcribed (35, 51) . Recent studies have shown that NSP1 acts as an adaptor that links the host Cullin-E3 ligase complex with β-transducin repeat-containing protein (β-TrCP), which is a necessary component for NF-κB-mediated induction of IFN transcripts (77, 78) . Through this interaction with the Cullin-E3 ligase complex, NSP1 facilitates the proteasomal degradation of itself and β-TrCP (78) . Using HIEs as a model, it was further shown that β-TrCP degradation by HRV was mitigated by inhibition of Cullin-RING ubiquitin ligases, demonstrating that HRV antagonizes IFN transcription by hijacking host proteins (78) . Although we did not evaluate this in our studies, this mechanism may help explain the lower levels of IFN transcripts observed when HIEs were infected with replication-competent HRV compared with inactivated HRV, which does not produce NSP1. Although replication-competent HRV inhibited type III IFN transcription ∼10-fold compared with inactivated HRV, type III IFN transcripts were still robustly induced in replication-competent HRV-infected HIEs (100-1,000 fold) and are present at high levels in intestinal epithelial cells from rotavirus-infected mice (54, 55) . Together, these data suggest that the transcriptional regulatory pathways upstream of IFN induction remain at least partially intact in these models. However, rotavirus can also inhibit host responses by decreasing translation of host mRNA through multiple mechanisms primarily via the protein NSP3 (24, (79) (80) (81) . Although these mechanisms do not selectively antagonize IFN, production of IFN protein is likely reduced when there is a global decrease in host translation. Thus, translational inhibition is a potent method for HRV to antagonize the type III IFN antiviral response because IFN-λ protein was significantly decreased in HIEs infected with replication-competent HRV compared with inactivated HRV. Because very low levels of IFN-λ protein are required to elicit the ISG responses observed in HRV-infected HIEs, our data suggest that minimal amounts of type III IFN protein were produced during HRV infection of HIEs: enough to induce ISGs but not enough to restrict viral growth. These results suggest there may be a threshold level of IFN production and perhaps ISG production needed to restrict viral growth. Overall, this represents the paradox of IFN responses in HIEs.
In contrast to HRV-infected HIEs, high levels of IFN-λ protein are detected in the small intestine from rotavirus-infected mice. These studies examined whole small intestinal homogenates; therefore, the cellular origin of the IFN-λ protein could not be determined (17, 54) . Murine intestinal epithelial cells were proposed to be the major source of IFN-λ protein in these homogenates because IFNL transcript levels were approximately four to five fold higher in intestinal epithelial cells than in hematopoietic cells (54) . However, our data demonstrate that IFNL transcripts do not parallel protein levels in epithelial cells during rotavirus infection. Hematopoietic cells can produce IFN-λ protein in response to multiple viruses (57) , and a recent study has demonstrated that steady-state IFN-λ in the intestine may actually originate from CD45 + hematopoietic cells rather than epithelial cells in uninfected mice (56) . Taken together, the HIE and mouse data suggest that the predominant source of the IFN-λ protein in the small intestine in response to rotavirus infection may be of hematopoietic rather than epithelial origin.
Lamina propria hematopoietic cells are the primary source of type I IFN during rotavirus infection in mice, rather than intestinal epithelial cells (58) . This is consistent with our data in which HIEs produced no detectable IFN-β protein in response to HRV, and blockade of the type I IFN system had minimal to no effect on transcription of the six ISGs assessed. These results suggest that the origin of type I IFN in humans, as in mice in vivo, is extraepithelial, such as from plasmacytoid dendritic cells (82) . We simulated the effect of extraepithelial sources of IFN by exogenously treating HIEs with IFN. Treatment with type I IFN-β was significantly more effective than type III IFN at restricting HRV replication. This differs from reports in mice, in which exogenous treatment with IFN-λ is more protective against enteric viral replication than type I IFN (55, 56) , and type I IFN is primarily considered to inhibit systemic spread of enteric viruses (17, 56, 75) . This difference may be a result of the type I IFN subtype tested; previous studies in mice and HIEs used an IFN-α subtype rather than IFN-β for exogenous treatment (17, 55, 56, 83) ; however, IFN-α2 was significantly weaker than IFN-β in restricting HRV growth in HIEs. Heterogeneity in the host response to different type I IFNs has been previously characterized; IFN-β binds the type I IFN receptor with greater affinity than IFN-α2 (84) , and other viral pathogens including LCMV and HCV have differing sensitivities to IFN-α and IFN-β (60). Thus, the choice of type I IFN tested may have a significant impact on the evaluation of IFN antiviral efficacy. Our data indicate that treatment with human type I IFN-β potently decreases local spread and replication of enteric viruses in the human intestinal epithelium, but whether extraepithelial production of type I IFN during infection in vivo is of sufficient quantity or interacts with epithelial cells to impact homologous virus replication remains a question. The ISGs required to limit HRV replication have yet to be identified, as individual ISG efficacy is virus-specific (31), but exogenous IFN-β likely induces these ISGs to higher levels and/or at a faster rate than IFN-λ in the human intestinal epithelium.
A current limitation of the HIE system is that it lacks the microbiome, and immune cells have yet to be incorporated with the epithelial cells to create a model that recapitulates the complex cross-talk that occurs in the small intestine (85, 86) . Although we partially simulated the role of immune cells on epithelial cells by exogenously adding IFN to HIE cultures, we were not able to evaluate the effects of epithelial-produced IFN-λ on immune cells. Plasmacytoid dendritic cells respond to exogenous IFN-λ as well as produce large amounts of type III and type I IFN protein (30, 57) . This raises the possibility of IFN-λ-mediated cross-talk between intestinal epithelial cells and intestinal plasmacytoid dendritic cells and leaves open the prospect that epithelial-derived IFN-λ can act on and even induce its own production from immune cells because IFN-λ is an ISG itself (87) . As HIE platforms and cellular coculture techniques are further developed, it will be possible to dissect such microbiome-immune-epithelial interactions.
To better understand infectious disease pathogenesis, hostpathogen interactions are studied in model systems. However, these models can yield differing results depending on the choice of host organism and pathogen strain. This is particularly relevant for human infections because modeling human pathogens in vivo is often impractical. Advances in the organoid/enteroid and transcriptomic fields provide much needed tools to study host-pathogen interactions in the human intestine. Recently, RNA-seq of iPSC-derived human intestinal organoids treated with the human enteric pathogen Salmonella enterica serovar Typhimurium revealed new insights into how the epithelium responds to bacterial infection with a proinflammatory transcriptional profile (3) . Like Salmonella Typhimurium, many human enteric viruses also lack robust models, and our studies demonstrate that HIEs are a useful model to study the human enteric virus HRV (9) . In the present study, a complex host-pathogen interplay between the human intestinal epithelial type III IFN system and viral antagonism of this response is described. Although epithelial-derived type III IFN has been proposed as a critical defense against murine enteric viruses (54-56), our data are consistent with a recent report showing type III IFN does not significantly restrict homologous murine rotavirus infection (17) . Even though the type III IFN system is activated in HIEs following HRV infection, the virus effectively evades this epithelial antiviral response. Whether other human enteric viruses similarly evade the type III IFN system remains to be determined. The recent cultivation of human noroviruses in HIEs establishes HIEs as a relevant model for studying host-pathogen interactions of other human enteric viruses in addition to HRV (4) . The limited role of type III IFN in restricting HRV replication in the human epithelium raises the question of whether virus-induced type III IFN has undiscovered biologic functions in the mucosal epithelium that are not directly antiviral but may have alternative effects on bystander epithelial and/or nonepithelial cells. Given that HIEs are derived from nontransformed human small intestinal tissue and can be generated from many different individuals, they provide a preclinical model for assessing the host response to human enteric pathogens and an additional system to evaluate if findings in animal models can be translated directly to human tissue or if important differences in these systems exist.
Materials and Methods
Detailed methods and descriptions of cell lines, HIE cultures, viruses and viral infections, immunohistochemistry, cytokines, antibodies, ELISA kits, RNA extraction, RT-qPCR protocols, and statistical analyses are provided in SI Materials and Methods.
Microarray-Based Transcriptome Analysis. HumanHT-12 v4 Expression BeadChips (Illumina) were used for microarray analysis. Transcriptome analysis was performed by using R statistical software (88) . Two microarray experiments were performed: the first experiment included samples from a single individual's HIEs (j11) and the second with samples of HIE cultures from three individuals (j2, j3, and j11). In the first and second microarray experiments, 20,948 genes were defined as expressed and used in subsequent analysis. Expression values for these 20,948 genes were quantile normalized by using the normalize.quantiles() function of the preprocessCore R library. Analysis of the microarray-acquired data is described in SI Materials and Methods.
RNA-seq-Based Transcriptome Analysis. Total RNA was prepared by using the Illumina TruSeq Stranded RNA Sample preparation protocol. Paired-end sequencing (100 bp) was performed by using the IlluminaHiSeq 2500 machine. A total of 103,002,651, 101,422,021, 90,511,554, and 84,412,802 reads were sequenced for samples j11-uninfected, j2-uninfected, j11-infected, and j2-infected, respectively. Analysis of the RNA-seq data are described in SI Materials and Methods.
